TapewireFind a company

person · Reporting owner

Schreuder Jana R

Disclosed activity across 5 companies

Tapewire entity
27145
SEC CIK
0001328600

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Bank of N.T. Butterfield & Son LtdNTB · Entity 4406DirectorOctober 01, 2026October 05, 2026
Kyndryl Holdings, Inc.KD · Entity 2161DirectorJuly 30, 2026August 03, 2026
NORTHERN TRUST CORPNTRS · Entity 1970COOAugust 06, 2018August 06, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Bank of N.T. Butterfield & Son Ltd

Report date October 01, 2026 · Filed October 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary sharesSEC Table I · non-derivativeDirect14,413 Reported balance After 2026-10-01 transaction · row 1
1 source row

Row 1 · 2026-10-01 · Grant · Acquired 1,178 · Balance 14,413

Kyndryl Holdings, Inc.

Report date July 30, 2026 · Filed August 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect77,930 Reported balance After 2026-07-30 transaction · row 1
1 source row

Row 1 · 2026-07-30 · Grant · Acquired 17,844 · Balance 77,930

F1: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).

NORTHERN TRUST CORP

Report date August 06, 2018 · Filed August 06, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirect2016 GRAT0 Reported balance After 2018-08-06 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2018-08-06 · Sale · Disposed 9,699 · Balance 0

F1: Price reflects the weighted average sales price from $110.00 to $110.01. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

Common StockSEC Table I · non-derivativeDirect44,716 Reported balance Holding disclosure · report date 2018-08-06 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 44,716

F2: Represents stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Common StockSEC Table I · non-derivativeIndirectBy Trust16,926 Reported balance Holding disclosure · report date 2018-08-06 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 16,926

Common StockSEC Table I · non-derivativeIndirect2017 GRAT9,882 Reported balance Holding disclosure · report date 2018-08-06 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 9,882

Common StockSEC Table I · non-derivativeIndirect2018 GRAT10,000 Reported balance Holding disclosure · report date 2018-08-06 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 10,000

Common StockSEC Table I · non-derivativeIndirect401(k) as of 6-30-1810,018.93 Reported balance Holding disclosure · report date 2018-08-06 · row 6 Holding and transaction disclosures are not merged.
1 source row

Row 6 · Balance 10,018.93

Filing footnotes · ownership attribution and instrument terms

F1: Price reflects the weighted average sales price from $110.00 to $110.01. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

F2: Represents stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AVANTAX, INC.

Report date November 27, 2023 · Filed November 29, 2023

Section 16 reporting ended · disclosed 2023-11-29. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2023-11-27 transaction · row 1
1 source row

Row 1 · 2023-11-27 · Disposition to issuer · Disposed 42,566 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger, dated as of September 9, 2023 (as may be amended from time to time, the "Merger Agreement") by and among the Issuer, Aretec Group, Inc., a Delaware corporation ("Parent"), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Acquisition Sub"), effective November 27, 2023, among other things, Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent.

F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), these shares of the Issuer's common stock ("Common Stock") and restricted stock units of the Issuer that vest solely on the basis of time ("RSUs") were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the reported number of shares multiplied by (ii) $26.00 (less any required tax withholdings).

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated as of September 9, 2023 (as may be amended from time to time, the "Merger Agreement") by and among the Issuer, Aretec Group, Inc., a Delaware corporation ("Parent"), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Acquisition Sub"), effective November 27, 2023, among other things, Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent.

F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), these shares of the Issuer's common stock ("Common Stock") and restricted stock units of the Issuer that vest solely on the basis of time ("RSUs") were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the reported number of shares multiplied by (ii) $26.00 (less any required tax withholdings).

LEGACY LIFEPOINT HEALTH, INC.

Report date November 16, 2018 · Filed November 20, 2018

Section 16 reporting ended · disclosed 2018-11-20. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-06-06Direct0 Reported balance After 2018-11-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2018-11-16 · Disposition to issuer · Disposed 3,379 · Balance 0

F1: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-03-10Direct0 Reported balance After 2018-11-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2018-11-16 · Disposition to issuer · Disposed 1,552 · Balance 0

F1: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2020-06-08Direct0 Reported balance After 2018-11-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2018-11-16 · Disposition to issuer · Disposed 3,008 · Balance 0

F1: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-06-08Direct0 Reported balance After 2018-11-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2018-11-16 · Disposition to issuer · Disposed 2,684 · Balance 0

F1: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 5, 2026 21:53 UTC Bank of N.T. Butterfield & Son Ltd NTB · Entity 4406 GrantOrdinary shares 1,178 $59.42 $69,996.76
Disclosure

SEC source: 0001653242-26-000137 · wk-form4_1791237236.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,413

Read SEC document
July 30, 2026 Filed Aug 3, 2026 21:41 UTC Kyndryl Holdings, Inc. KD · Entity 2161 GrantCommon Stock 17,844 $13.45 $240,001.80
Disclosure

SEC source: 0001328600-26-000002 · form4-08032026_090842.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,930

F1 · shares: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).

Read SEC document
July 31, 2025 Filed Aug 1, 2025 21:04 UTC Kyndryl Holdings, Inc. KD · Entity 2161 GrantCommon Stock 6,296 $38.12 $240,003.52
Disclosure

SEC source: 0001127602-25-019869 · form4.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,086

F1 · shares: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2026 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2025 Annual Meeting of Stockholders).

Read SEC document
July 25, 2024 Filed Jul 29, 2024 21:01 UTC Kyndryl Holdings, Inc. KD · Entity 2161 GrantCommon Stock 7,787 $26.97 $210,015.39
Disclosure

SEC source: 0001127602-24-021105 · form4.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,790

F1 · shares: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2025 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2024 Annual Meeting of Stockholders).

Read SEC document
November 27, 2023 Filed Nov 29, 2023 15:11 UTC AVANTAX, INC. AVTA · Entity 107910 Disposition to issuerCommon Stock 42,566 $26.00 $1,106,716.00
Disclosure

SEC source: 0001068875-23-000124 · wk-form4_1701288683.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of September 9, 2023 (as may be amended from time to time, the "Merger Agreement") by and among the Issuer, Aretec Group, Inc., a Delaware corporation ("Parent"), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Acquisition Sub"), effective November 27, 2023, among other things, Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent.

F2 · kind: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), these shares of the Issuer's common stock ("Common Stock") and restricted stock units of the Issuer that vest solely on the basis of time ("RSUs") were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the reported number of shares multiplied by (ii) $26.00 (less any required tax withholdings).

Read SEC document
July 27, 2023 Filed Jul 31, 2023 21:30 UTC Kyndryl Holdings, Inc. KD · Entity 2161 GrantCommon Stock 15,614 $13.45 $210,008.30
Disclosure

SEC source: 0001127602-23-021585 · form4.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,003

F1 · shares: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2024 annual meeting of stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2023 annual meeting of stockholders).

Read SEC document
May 04, 2023 Filed May 8, 2023 16:45 UTC AVANTAX, INC. AVTA · Entity 107910 GrantCommon Stock 6,084 $0.00 $0.00
Disclosure

SEC source: 0001068875-23-000084 · wf-form4_168357872803893.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,566

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on May 4, 2023 and that will vest on the earlier of the one-year anniversary of the date of grant or the first annual shareholder's meeting after the grant date.

Read SEC document
July 28, 2022 Filed Aug 1, 2022 21:27 UTC Kyndryl Holdings, Inc. KD · Entity 2161 GrantCommon Stock 19,399 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-005795 · primarydocument.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,389

F1 · shares: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2023 annual meeting of stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2022 annual meeting of stockholders).

Read SEC document
May 23, 2022 Filed Jan 20, 2023 21:22 UTC AVANTAX, INC. BCOR · Entity 107910 GrantCommon Stock 1,213 $0.00 $0.00
Disclosure

SEC source: 0001068875-23-000025 · wf-form4_167426772439297.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,482

F1 · shares: Reflects a grant of restricted stock units that will vest on the earlier of the one-year anniversary of the date of grant or the first annual stockholders meeting after the grant date.

Read SEC document
April 20, 2022 Filed Apr 22, 2022 18:21 UTC AVANTAX, INC. BCOR · Entity 107910 GrantCommon Stock 5,946 $0.00 $0.00
Disclosure

SEC source: 0001068875-22-000060 · wf-form4_165066607228285.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,269

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 20, 2022 and that will vest on the earlier of the one-year anniversary of the date of grant or the first annual meeting of stockholders after the grant date.

Read SEC document
December 16, 2021 Filed Dec 20, 2021 21:38 UTC Kyndryl Holdings, Inc. KD · Entity 2161 GrantCommon Stock 10,990 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-007786 · primarydocument.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,990

F1 · shares: Represents a grant of restricted stock units which will vest in full on the anniversary of the grant date.

Read SEC document
April 26, 2021 Filed Apr 28, 2021 17:21 UTC AVANTAX, INC. BCOR · Entity 107910 GrantCommon Stock 8,012 $0.00 $0.00
Disclosure

SEC source: 0001068875-21-000058 · wf-form4_161964488784752.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,323

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that was made to the Reporting Person on April 26, 2021 and that will vest on the earlier of the one-year anniversary of the date of grant or the first annual stockholders meeting following such date of grant.

Read SEC document
May 21, 2020 Filed May 26, 2020 17:13 UTC AVANTAX, INC. BCOR · Entity 107910 GrantCommon Stock 11,061 $0.00 $0.00
Disclosure

SEC source: 0001068875-20-000117 · wf-form4_159052758580759.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,311

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that will vest on the earlier of the one-year anniversary of the date of grant or the first annual stockholders meeting after the grant date.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 16:28 UTC AVANTAX, INC. BCOR · Entity 107910 GrantCommon Stock 10,250 $0.00 $0.00
Disclosure

SEC source: 0001068875-20-000067 · wf-form4_158327090327010.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,250

F1 · shares: Reflects (i) an initial grant of 8,620 restricted stock units ("RSUs") that was made to the reporting person upon joining the Board of Directors that will vest equally over a three-year period on each anniversary of the grant date, and (ii) a pro-rated annual grant of 1,630 RSUs that will vest on the one-year anniversary of the date of grant.

Read SEC document
November 16, 2018 Filed Nov 20, 2018 21:50 UTC LEGACY LIFEPOINT HEALTH, INC. LPNT · Entity 162283 Disposition to issuerRestricted Stock Units · Derivative 2,684 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001225208-18-015778 · doc4.xml · derivative · entry 4

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 2,684 shares

Expires 2019-06-08

F1 · derivative.exercise_price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · kind: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Read SEC document
November 16, 2018 Filed Nov 20, 2018 21:50 UTC LEGACY LIFEPOINT HEALTH, INC. LPNT · Entity 162283 Disposition to issuerRestricted Stock Units · Derivative 3,008 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001225208-18-015778 · doc4.xml · derivative · entry 3

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 3,008 shares

Expires 2020-06-08

F1 · derivative.exercise_price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · kind: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Read SEC document
November 16, 2018 Filed Nov 20, 2018 21:50 UTC LEGACY LIFEPOINT HEALTH, INC. LPNT · Entity 162283 Disposition to issuerRestricted Stock Units · Derivative 1,552 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001225208-18-015778 · doc4.xml · derivative · entry 2

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 1,552 shares

Expires 2019-03-10

F1 · derivative.exercise_price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · kind: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Read SEC document
November 16, 2018 Filed Nov 20, 2018 21:50 UTC LEGACY LIFEPOINT HEALTH, INC. LPNT · Entity 162283 Disposition to issuerRestricted Stock Units · Derivative 3,379 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001225208-18-015778 · doc4.xml · derivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 3,379 shares

Expires 2021-06-06

F1 · derivative.exercise_price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · kind: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · price: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

F1 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each outstanding restricted stock unit, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of common stock subject to such restricted stock unit award.

Read SEC document
August 06, 2018 Filed Aug 6, 2018 22:55 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 9,699 $110.00 $1,066,890.00
Disclosure

SEC source: 0000073124-18-000262 · wf-form4_153359611550497.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · 2016 GRAT

Disclosed balance after: 0

F1 · price: Price reflects the weighted average sales price from $110.00 to $110.01. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 18:10 UTC LEGACY LIFEPOINT HEALTH, INC. LPNT · Entity 162283 GrantRestricted Stock Units · Derivative 3,379 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-18-010434 · doc4.xml · derivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,379

Underlying: Common · 3,379 shares

Expires 2021-06-06

F1 · derivative.exercise_date: Generally, this award will be forfeited in its entirety unless the reporting person continues to serve as a director of the Company on the date that is 12 months from the date of grant. The award will be settled on the third anniversary of the date of grant.

Read SEC document
May 15, 2018 Filed May 16, 2018 23:09 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 2,913 $107.38 $312,797.94
Disclosure

SEC source: 0000073124-18-000216 · wf-form4_152651217111576.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 16,926

F1 · price: Price reflects the weighted average sales price from $107.35 to $107.44. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

Read SEC document
April 24, 2018 Filed Apr 24, 2018 22:30 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 2,627 $108.08 $283,926.16
Disclosure

SEC source: 0000073124-18-000196 · wf-form4_152460903286324.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · 2015 GRAT

Disclosed balance after: 0

F1 · price: Price reflects the weighted average sales price from $108.08 to $108.12. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 21:27 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 4,807 $110.00 $528,770.00
Disclosure

SEC source: 0000073124-18-000153 · wf-form4_152097640643534.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 16,926

F1 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 23:25 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 3,730 $105.14 $392,172.20
Disclosure

SEC source: 0000073124-18-000149 · wf-form4_152003308075022.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 21,733

F1 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F2 · price: Price reflects the weighted average sales price from $105.00 to $105.33. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

F3 · balance_after: Reflects the March 1, 2018 transfer of 10,000 shares of the Corporation's common stock from the reporting person's existing trust into a newly created grantor retained annuity trust.

Read SEC document
February 20, 2018 Filed Feb 22, 2018 22:08 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GrantCommon Stock 10,027 $0.00 $0.00
Disclosure

SEC source: 0000073124-18-000133 · wf-form4_151933729117145.xml · nonDerivative · entry 2

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,716

F2 · balance_after: Represents stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
February 20, 2018 Filed Feb 22, 2018 22:08 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Tax withholdingCommon Stock 1,972 $105.15 $207,355.80
Disclosure

SEC source: 0000073124-18-000133 · wf-form4_151933729117145.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,689

F1 · balance_after: Reflects 1,972 shares withheld in payment of Federal, State and Medicare taxes upon the vesting of 4,451 previously reported stock units. The remaining 2,479 shares were distributed to the reporting person as shares of common stock and transferred to the reporting person's existing trust account.

F2 · balance_after: Represents stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
February 14, 2018 Filed Feb 14, 2018 23:34 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GiftCommon Stock 936 $0.00 $0.00
Disclosure

SEC source: 0000073124-18-000095 · wf-form4_151865123019894.xml · nonDerivative · entry 2

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 32,984

F1 · balance_after: Reflects 1,820 shares withheld in payment of Federal, State and Medicare taxes upon the vesting of 4,108 previously reported stock units. The remaining 2,288 shares were distributed to the reporting person as shares of common stock and transferred to the reporting person's existing trust account.

F3 · balance_after: Reflects the January 31, 2018 distribution of 2,626 shares from the reporting person's grantor retained annuity trust to the reporting person's existing trust as an annuity payment in accordance with the terms of the GRAT instrument.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 23:34 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Tax withholdingCommon Stock 1,820 $98.88 $179,961.60
Disclosure

SEC source: 0000073124-18-000095 · wf-form4_151865123019894.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,140

F1 · balance_after: Reflects 1,820 shares withheld in payment of Federal, State and Medicare taxes upon the vesting of 4,108 previously reported stock units. The remaining 2,288 shares were distributed to the reporting person as shares of common stock and transferred to the reporting person's existing trust account.

F2 · balance_after: Represents stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
January 23, 2018 Filed Jan 25, 2018 23:05 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Tax withholdingCommon Stock 7,728 $106.71 $824,654.88
Disclosure

SEC source: 0000073124-18-000045 · wf-form4_151692154180315.xml · nonDerivative · entry 3

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,248

F2 · balance_after: Includes 43,248 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

F3 · balance_after: Reflects the transfer of 12,159 shares directly held by the reporting person into the reporting person's existing trust account.

Read SEC document
January 23, 2018 Filed Jan 25, 2018 23:05 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GrantCommon Stock 19,887 $106.71 $2,122,141.77
Disclosure

SEC source: 0000073124-18-000045 · wf-form4_151692154180315.xml · nonDerivative · entry 2

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,135

F2 · balance_after: Includes 43,248 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
December 15, 2017 Filed Jan 25, 2018 23:05 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Tax withholdingCommon Stock 352 $97.29 $34,246.08
Disclosure

SEC source: 0000073124-18-000045 · wf-form4_151692154180315.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,248

F1 · shares: Represents shares withheld to satisfy tax withholding obligations related to previously reported stock units.

F2 · balance_after: Includes 43,248 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
December 04, 2017 Filed Dec 4, 2017 23:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionEmployee Stock Option (right-to-buy) · Derivative 15,889 $0.00 Strike: $60.85 $0.00
Disclosure

SEC source: 0000073124-17-000319 · wf-form4_151243119365314.xml · derivative · entry 11

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,162

Underlying: Common Stock · 15,889 shares

Expires 2024-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F5 · derivative.exercise_date: This option becomes exercisable in four equal annual installments beginning 2/10/2015.

Read SEC document
December 04, 2017 Filed Dec 4, 2017 23:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 15,889 $99.23 $1,576,665.47
Disclosure

SEC source: 0000073124-17-000319 · wf-form4_151243119365314.xml · nonDerivative · entry 4

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,600

F2 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F4 · price: Price reflects the weighted average sales price from $99.00 to $99.55. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

F1 · balance_after: Includes 43,600 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
December 04, 2017 Filed Dec 4, 2017 23:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionCommon Stock 15,889 $60.85 $966,845.65
Disclosure

SEC source: 0000073124-17-000319 · wf-form4_151243119365314.xml · nonDerivative · entry 3

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2017 Filed Dec 4, 2017 23:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionEmployee Stock Option (right-to-buy) · Derivative 2,600 $0.00 Strike: $60.85 $0.00
Disclosure

SEC source: 0000073124-17-000319 · wf-form4_151243119365314.xml · derivative · entry 10

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,051

Underlying: Common Stock · 2,600 shares

Expires 2024-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F5 · derivative.exercise_date: This option becomes exercisable in four equal annual installments beginning 2/10/2015.

Read SEC document
November 30, 2017 Filed Dec 4, 2017 23:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 2,600 $99.02 $257,452.00
Disclosure

SEC source: 0000073124-17-000319 · wf-form4_151243119365314.xml · nonDerivative · entry 2

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,600

F2 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F3 · price: Price reflects the weighted average sales price from $99.00 to $99.04. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

F1 · balance_after: Includes 43,600 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
November 30, 2017 Filed Dec 4, 2017 23:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionCommon Stock 2,600 $60.85 $158,210.00
Disclosure

SEC source: 0000073124-17-000319 · wf-form4_151243119365314.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 43,600 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
September 11, 2017 Filed Sep 12, 2017 23:00 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 5,581 $90.00 $502,290.00
Disclosure

SEC source: 0000073124-17-000269 · wf-form4_150525718767222.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 16,847

Read SEC document
August 07, 2017 Filed Aug 7, 2017 23:04 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 5,538 $88.33 $489,171.54
Disclosure

SEC source: 0000073124-17-000253 · wf-form4_150214703609889.xml · nonDerivative · entry 3

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Child

Disclosed balance after: 0

F2 · price: Price reflects the weighted average sales price from $88.17 to $88.58. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

Read SEC document
August 03, 2017 Filed Aug 7, 2017 23:04 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GiftCommon Stock 5,538 $0.00 $0.00
Disclosure

SEC source: 0000073124-17-000253 · wf-form4_150214703609889.xml · nonDerivative · entry 2

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Child

Disclosed balance after: 5,538

F1 · balance_after: On August 3, 2017, the reporting person's grantor retained annuity trust ("GRAT") distributed 1,791 shares of the Corporation's common stock to the reporting person's existing revocable trust as an annuity payment. On such date 5,538 shares also were distributed to the reporting person's child. Each distribution was made in accordance with the terms of the GRAT instrument.

Read SEC document
August 03, 2017 Filed Aug 7, 2017 23:04 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GiftCommon Stock 5,538 $0.00 $0.00
Disclosure

SEC source: 0000073124-17-000253 · wf-form4_150214703609889.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · 2012 GRAT

Disclosed balance after: 1,791

F1 · balance_after: On August 3, 2017, the reporting person's grantor retained annuity trust ("GRAT") distributed 1,791 shares of the Corporation's common stock to the reporting person's existing revocable trust as an annuity payment. On such date 5,538 shares also were distributed to the reporting person's child. Each distribution was made in accordance with the terms of the GRAT instrument.

Read SEC document
June 07, 2017 Filed Jun 9, 2017 16:52 UTC LEGACY LIFEPOINT HEALTH, INC. LPNT · Entity 162283 GrantRestricted Stock Units · Derivative 3,008 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-17-011088 · doc4.xml · derivative · entry 1

Schreuder Jana R · CIK 0001328600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,008

Underlying: Common · 3,008 shares

Expires 2020-06-08

F1 · shares: Generally, this award will be forfeited in its entirety unless the reporting person continues to serve as a director of the Company on the date that is 6 months plus 1 day from the date of grant. The award will be settled on the third anniversary of the date of grant.

Read SEC document
May 16, 2017 Filed May 17, 2017 21:45 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GiftCommon Stock 1,230 $0.00 $0.00
Disclosure

SEC source: 0000073124-17-000204 · wf-form4_149505750704641.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 20,637

Read SEC document
May 08, 2017 Filed May 8, 2017 23:13 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Disposition to issuerCommon Stock 6,405 $90.51 $579,716.55
Disclosure

SEC source: 0000073124-17-000198 · wf-form4_149428517515612.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 21,867

F1 · price: Price reflects the weighted average sales price from $90.50 to $90.54. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request.

F2 · balance_after: Reflects the May 2, 2017 distribution of 1,542 shares from the reporting person's grantor retained annuity trust to the reporting person's existing trust as an annuity payment in accordance with the terms of the GRAT instrument.

Read SEC document
April 28, 2017 Filed Apr 28, 2017 23:20 UTC NORTHERN TRUST CORP NTRS · Entity 1970 GiftCommon Stock 293 $0.00 $0.00
Disclosure

SEC source: 0000073124-17-000188 · wf-form4_149342162533442.xml · nonDerivative · entry 3

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 26,730

Read SEC document
April 26, 2017 Filed Apr 28, 2017 23:20 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionEmployee Stock Option (right-to-buy) · Derivative 28,469 $0.00 Strike: $52.69 $0.00
Disclosure

SEC source: 0000073124-17-000188 · wf-form4_149342162533442.xml · derivative · entry 9

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,469 shares

Expires 2023-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option becomes exercisable in four equal annual installments beginning 2/11/2014.

Read SEC document
April 26, 2017 Filed Apr 28, 2017 23:20 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 28,469 $92.00 $2,619,148.00
Disclosure

SEC source: 0000073124-17-000188 · wf-form4_149342162533442.xml · nonDerivative · entry 2

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,600

F2 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F1 · balance_after: Includes 43,600 shares representing stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
April 26, 2017 Filed Apr 28, 2017 23:20 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionCommon Stock 28,469 $52.69 $1,500,031.61
Disclosure

SEC source: 0000073124-17-000188 · wf-form4_149342162533442.xml · nonDerivative · entry 1

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 43,600 shares representing stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document
March 16, 2017 Filed Mar 16, 2017 22:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 Exercise / conversionEmployee Stock Option (right-to-buy) · Derivative 11,600 $0.00 Strike: $52.64 $0.00
Disclosure

SEC source: 0000073124-17-000127 · wf-form4_148970439795588.xml · derivative · entry 12

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,600 shares

Expires 2021-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option became exercisable in four equal annual installments beginning 2/14/2012.

Read SEC document
March 16, 2017 Filed Mar 16, 2017 22:46 UTC NORTHERN TRUST CORP NTRS · Entity 1970 SaleCommon Stock 11,600 $90.00 $1,044,000.00
Disclosure

SEC source: 0000073124-17-000127 · wf-form4_148970439795588.xml · nonDerivative · entry 4

Schreuder Jana R · CIK 0001328600 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,600

F2 · kind: This transaction was effected pursuant to a trading plan adopted in accordance with SEC Rule 10b5-1.

F1 · balance_after: Includes 43,600 shares representing stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.